PAS
DGX icon

Park Avenue Securities’s Quest Diagnostics DGX Stock Holding History

Park Avenue Securities’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.04M Buy
9,611
+404
+4% +$79.3K 0.01% 669
2026
Q1 		$1.8M Buy
9,207
+3,200
+53% +$622K 0.01% 590
2025
Q4 		$1.04M Buy
6,007
+45
+0.8% +$8.19K 0.01% 788
2025
Q3 		$1.14M Sell
5,962
-27
-0.5% -$4.79K 0.01% 828
2025
Q2 		$1.08M Sell
5,989
-192
-3% -$33.3K 0.01% 757
2025
Q1 		$1.05M Buy
6,181
+1,012
+20% +$166K 0.01% 605
2024
Q4 		$780K Buy
5,169
+955
+23% +$149K 0.01% 876
2024
Q3 		$654K Buy
4,214
+1,049
+33% +$157K 0.01% 870
2024
Q2 		$433K Buy
3,165
+94
+3% +$12.9K 0.01% 1028
2024
Q1 		$409K Sell
3,071
-538
-15% -$69.8K 0.01% 1050
2023
Q4 		$498K Sell
3,609
-546
-13% -$71.8K 0.01% 912
2023
Q3 		$506K Buy
+4,155
New +$554K 0.01% 826
2023
Q1 		– Sell
-5,875
Closed -$919K – 808
2022
Q4 		$919K Buy
5,875
+176
+3% +$25.3K 0.02% 563
2022
Q3 		$699K Buy
5,699
+288
+5% +$37.9K 0.01% 601
2022
Q2 		$720K Buy
5,411
+2,862
+112% +$390K 0.01% 578
2022
Q1 		$349K Buy
2,549
+38
+2% +$5.3K 0.01% 893
2021
Q4 		$434K Buy
2,511
+221
+10% +$33.6K 0.01% 773
2021
Q3 		$333K Buy
2,290
+238
+12% +$34.8K 0.01% 818
2021
Q2 		$271K Sell
2,052
-2,163
-51% -$283K 0.01% 880
2021
Q1 		$541K Buy
4,215
+628
+18% +$77.4K 0.01% 559
2020
Q4 		$427K Buy
3,587
+140
+4% +$17.1K 0.01% 546
2020
Q3 		$395K Sell
3,447
-14
-0.4% -$1.65K 0.01% 494
2020
Q2 		$394K Buy
+3,461
New +$367K 0.01% 433
2018
Q3 		– Sell
-3,015
Closed -$332K – 215
2018
Q2 		$332K Buy
3,015
+380
+14% +$39.6K 0.06% 102
2018
Q1 		$258K Buy
+2,635
New +$270K 0.06% 112
2017
Q4 		– Sell
-2,914
Closed -$273K – 130
2017
Q3 		$273K Buy
+2,914
New +$309K 0.08% 70

Other funds holding DGX

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BCAM
Boston Common Asset Management Boston, Massachusetts $1.69B AUM 28.29% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Park Avenue Securities's DGX Position: Q2 2026 in Review

Park Avenue Securities increased its Quest Diagnostics (DGX) stake by 4.4% in Q2 2026, buying an estimated $79.3K and bringing the position to 9,611 shares worth $2.04M. The position accounts for 0.01% of the portfolio, ranked #669.

Park Avenue Securities first reported a position in DGX in Q3 2017 and has held it in 26 quarters since. 287 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Park Avenue Securities held 9,611 shares of Quest Diagnostics worth $2.04M as of Q2 2026.
  • Park Avenue Securities bought 404 Quest Diagnostics shares in Q2 2026, an estimated $79.3K.
  • Quest Diagnostics made up 0.01% of Park Avenue Securities's portfolio in Q2 2026, its #669 holding.
  • Park Avenue Securities first reported a position in Quest Diagnostics in Q3 2017 and has held it in 26 quarters since.
  • 287 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.